REQUEST A DEMO
Total
USD $0.00
Search more companies

Nanolek OOO (Нанолек ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Nanolek OOO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

nanolek is a biotechnology company that specializes in producing import replacement and innovative medicines for the prevention and treatment of socially significant diseases. nanolek complies with international GMP and ISO standards for medicine production and has exclusive rights for distribution, promotion, pharmacovigilance, and quality control of certain medications in Russia and the countries of the Eurasian Economic Union. The company prioritizes patient safety and conducts safety monitoring to minimize risks associated with the use of its products.

Headquarters
Butyrskii Val, 68/70, 1, 2 Pom I Kom 23-37
Moscow; Moscow; Postal Code: 127055

Contact Details: Purchase the Nanolek OOO (Нанолек ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Nanolek OOO (Нанолек ООО) report to view the information.
Registered Capital:
Purchase the Nanolek OOO (Нанолек ООО) report to view the information.
Financial Auditors:
Purchase the Nanolek OOO (Нанолек ООО) report to view the information.
Incorporation Date:
April 28, 2011
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Immolab OOO
99%
Invak OOO
60%
Company Performance
Financial values in the chart are available after Nanolek OOO (Нанолек ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
39.63%
Total operating revenue
39.63%
Operating Profit/Loss (EBIT)
11.81%
Net Profit/Loss for the Period
-50.4%
Total Assets
0.13%
Total Equity
-6.69%
Operating Profit Margin (ROS)
-2.82%
Net Profit Margin
-3.94%
Return on Equity (ROE)
-12.26%
Debt/Equity
48.1%
Quick Ratio
0.14%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?